-otermin
Versions of bone morphogenetic proteins, which drive bone growth.
- Drugs ending in -otermin: 4
- Approved somewhere: 2
- With a US drug page: 0
- Stem
- -otermin
- Class
- Versions of bone morphogenetic proteins, which drive bone growth
- Sub-stem of
- -ermin: Versions of the body's growth factor proteins
Approved and clinical-stage drugs in ChEMBL whose names ending in -otermin, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Dibotermin alfa | Approved | BMPR1A, ACVR2B, BMPR2, BMPR1B and 2 more | Bone morphogenetic protein receptor type-1A agonist |
| Eptotermin alfa | Approved | BMPR1A, BMPR2, BMPR1B, ACVR1 | Bone morphogenetic protein receptor type-1A agonist |
| Avotermin | Phase 3 | — | — |
| Radotermin | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO